About Hirslanden
Hirslanden is a company based in Geneve (Switzerland) founded in 1990 was acquired by Mediclinic in August 2007. It operates as a Professional Services and HealthTech. Hirslanden offers products and services including Preventive Healthcare, Cancer and Oncology, Fertility Treatment, Heart and Circulatory System Care, and Second Opinion and Telemedicine.
- Headquarter Geneve, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hirslanden Group
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Mediclinic
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hirslanden
Hirslanden offers a comprehensive portfolio of products and services, including Preventive Healthcare, Cancer and Oncology, Fertility Treatment, Heart and Circulatory System Care, and Second Opinion and Telemedicine.
Preventive care is provided to maintain patient health.
Oncology treatments are offered for cancer patient care.
Fertility solutions are delivered for reproductive health support.
Cardiac care is provided for heart-related conditions.
Remote consultations are offered for diagnosis and advice.
Funding Insights of Hirslanden
Detailed funding history for Hirslanden
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Hirslanden
Hirslanden has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Mediclinic and BC Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified alternative assets are managed through investment strategies.
|
Locked | Locked | Locked | |
|
Multispeciality hospitals are operated across multiple locations.
|
Locked | Locked | Locked |
Investor details for Hirslanden
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hirslanden
Investment portfolio details for Hirslanden
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hirslanden
Detailed financials for Hirslanden
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hirslanden Comparisons
Peer comparison for Hirslanden
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hirslanden
Detailed competitors of Hirslanden
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hirslanden
Complete news archive for Hirslanden
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hirslanden
Hirslanden was founded in 1990.
Hirslanden is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Ole Wiesinger is the current CEO of Hirslanden.
Hirslanden Group is established as the largest private hospital group in Switzerland, operating 17 hospitals and over 100 competence centers. A wide range of medical services, including preventive healthcare, cancer treatment, fertility solutions, and cardiac care, are provided. Specialized treatments such as CAR T-Cell therapy and in vitro fertilization are offered alongside telemedicine and second opinion services. The focus is placed on delivering high standards in medicine and personalized care across various disciplines. International patients are supported with dedicated case managers and tailored healthcare solutions.
Hirslanden offers Preventive Healthcare, Cancer and Oncology, Fertility Treatment, Heart and Circulatory System Care, and Second Opinion and Telemedicine.
Hirslanden has 2 investors. Key investors include Mediclinic, and BC Partners.